Results 11 to 20 of about 3,930 (214)

Glucosylceramidase Maintains Influenza Virus Infection by Regulating Endocytosis [PDF]

open access: hybridJournal of Virology, 2019
Influenza virus is the pathogen responsible for the second largest pandemic in human history. A better understanding of how influenza virus enters host cells may lead to the development of more-efficacious therapies against emerging strains of the virus.
Kelly Drews   +11 more
semanticscholar   +4 more sources

Identification of the Non-lysosomal Glucosylceramidase as β-Glucosidase 2 [PDF]

open access: hybridJournal of Biological Chemistry, 2006
The primary catabolic pathway for glucosylceramide is catalyzed by the lysosomal enzyme glucocerebrosidase that is defective in Gaucher disease patients.
Rolf G. Boot   +7 more
semanticscholar   +7 more sources

Functional and genetic characterization of the non-lysosomal glucosylceramidase 2 as a modifier for Gaucher disease [PDF]

open access: goldOrphanet Journal of Rare Diseases, 2013
BackgroundGaucher disease (GD) is the most common inherited lysosomal storage disorder in humans, caused by mutations in the gene encoding the lysosomal enzyme glucocerebrosidase (GBA1).
Yildiz Yildiz   +17 more
semanticscholar   +8 more sources

Molecular Basis of Reduced Glucosylceramidase Activity in the Most Common Gaucher Disease Mutant, N370S [PDF]

open access: hybridJournal of Biological Chemistry, 2010
Gaucher disease is caused by the defective activity of the lysosomal hydrolase, glucosylceramidase. Although the x-ray structure of wild type glucosylceramidase has been resolved, little is known about the structural features of any of the >200 mutations.
Marc N. Offman   +4 more
semanticscholar   +5 more sources

A Fluorescence Polarization Activity-Based Protein Profiling Assay in the Discovery of Potent, Selective Inhibitors for Human Nonlysosomal Glucosylceramidase [PDF]

open access: hybridJournal of the American Chemical Society, 2017
Human nonlysosomal glucosylceramidase (GBA2) is one of several enzymes that controls levels of glycolipids and whose activity is linked to several human disease states.
D. Lahav   +17 more
semanticscholar   +8 more sources

Glucosylceramidase Mass and Subcellular Localization Are Modulated by Cholesterol in Niemann-Pick Disease Type C [PDF]

open access: hybridJournal of Biological Chemistry, 2004
Niemann-Pick disease type C (NPC) is characterized by the accumulation of cholesterol and sphingolipids in the late endosomal/lysosomal compartment. The mechanism by which the concentration of sphingolipids such as glucosylceramide is increased in this ...
Rosa Salvioli   +6 more
semanticscholar   +6 more sources

Function of saposin C in the reconstitution of glucosylceramidase by phosphatidylserine liposomes [PDF]

open access: bronzeFEBS Letters, 1993
The function of saposin C (Sap C), a glucosylceramidase activator protein, in the enzyme stimulation by phosphatidylserine (PS) liposomes has been investigated. Using gel filtration experiments evidence was obtained for Sap C binding to PS large unilamellar vesicles (LUV) but not to glucosylceramidase.
Anna Maria Vaccaro   +5 more
semanticscholar   +5 more sources

Erratum to: Current and Novel Aspects on the Non-lysosomal β-Glucosylceramidase GBA2 [PDF]

open access: bronzeNeurochemical Research, 2016
Massimo Aureli   +8 more
semanticscholar   +4 more sources

Home - About - Disclaimer - Privacy